402832-69-3 Usage
Description
(2S,6S)-2,6-dimethylpiperazine, a chemical compound with the molecular formula C6H14N2, is a piperazine derivative characterized by the presence of two methyl groups attached to the 2 and 6 positions of the piperazine ring. This chiral compound is known for its unique structural features, making it a valuable and versatile compound in the field of organic chemistry and drug development.
Uses
Used in Pharmaceutical Industry:
(2S,6S)-2,6-diMethylpiperazine is used as a building block for the synthesis of various drug molecules, contributing to the development of new pharmaceuticals with improved therapeutic properties.
Used in Organic Synthesis:
(2S,6S)-2,6-diMethylpiperazine serves as a reagent in the synthesis of new organic compounds, facilitating the creation of complex molecules with potential applications in various industries.
Used as an Intermediate in Drug Manufacturing:
(2S,6S)-2,6-diMethylpiperazine is utilized as an intermediate in the manufacturing process of pharmaceutical drugs, playing a crucial role in the production of effective and safe medications.
Used in the Preparation of Complex Molecules:
(2S,6S)-2,6-diMethylpiperazine acts as a starting material for the preparation of complex molecules, enabling the synthesis of advanced chemical entities with diverse applications in research and industry.
Check Digit Verification of cas no
The CAS Registry Mumber 402832-69-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,2,8,3 and 2 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 402832-69:
(8*4)+(7*0)+(6*2)+(5*8)+(4*3)+(3*2)+(2*6)+(1*9)=123
123 % 10 = 3
So 402832-69-3 is a valid CAS Registry Number.
402832-69-3Relevant articles and documents
QUINOLINE DERIVATIVES AS SMO INHIBITORS
-
Paragraph 0088; 0095, (2017/02/28)
Disclosed are quinoline derivatives as hedgehog pathway inhibitors, especially as SMO inhibitors. Compounds of the present invention can be used in treating diseases relating to hedgehog pathway including cancer.
Process for preparing Cis-2,6-dimethylpiperazine
-
Example 2, (2008/06/13)
This invention relates to a process for the selective preparation of cis-2,6-dimethylpiperazine by reacting (i) a diisopropanolamine mixture comprising compounds having the formulas HN(CH2CH(OH)CH3)2, HN(CH(CH3)CH2OH)2, and HN(CH(CH3)CH2OH)(CH2CH(OH)CH3) or (ii) 1,2-diaminopropane with ammonia and hydrogen in the presence of a hydrogenation catalyst.
